MUC2 and colorectal cancer: Therefore, the age of 3 months might be the key point at which chronic colitis progresses to colorectal cancer, i.e. colitis malignant transformation, and the Muc2 mice could be one of the best engineered models of colitis-associated cancer to dynastically study the mechanism of malignant transformation of chronic colitis.